LUCD Insider Trading Activity and SEC Form 4 Filings
LUCD insider trading summary
Over the past 12 months, insiders at Lucid Diagnostics Inc. (LUCD) reported 1 open-market purchase worth $245K by 1 insider and no sales on SEC Form 4. Net insider buying was $245K.
Latest LUCD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 20, 2026 | Dennis Matheis | Director | Buy | $245K (245,000 @ $1.00) |
| Aug 20, 2025 | Dennis Matheis | Director | Buy | $102K (100,000 @ $1.02) |
| May 22, 2025 | Dennis Matheis | Director | Buy | $44K (33,218 @ $1.32) |
| May 21, 2025 | Dennis Matheis | Director | Buy | $172K (129,684 @ $1.32) |
| May 20, 2025 | Dennis Matheis | Director | Buy | $242K (187,098 @ $1.29) |
| Sep 26, 2023 | Stanley Lapidus | Director | Sell | $14K (9,747 @ $1.45) |
| Sep 26, 2023 | Stanley Lapidus | Director | Sell | $14K (10,000 @ $1.43) |
| Sep 26, 2023 | Stanley Lapidus | Director | Sell | $15K (10,000 @ $1.47) |
| Sep 25, 2023 | Stanley Lapidus | Director | Sell | $286 (200 @ $1.43) |
| Sep 21, 2023 | Stanley Lapidus | Director | Sell | $144 (100 @ $1.44) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.